诺华计划在华投资超33亿元人民币

Core Viewpoint - Novartis announced its commitment to increase investment in China, with plans to invest over 3.3 billion RMB to expand its research, production, and operational presence in the country [1] Group 1 - Novartis will continue to introduce innovative drugs for Chinese patients [1] - The announcement was made during the China Development Forum 2026 annual meeting [1] - CEO Vas Narasimhan emphasized the company's ongoing dedication to the Chinese market [1]